NCT00947336View on ClinicalTrials.gov

Evaluation of Safety & Efficacy of Synbiotic on the Incidence and Recurrence of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Cirrhosis With Ascites
Interventions
DRUG

Norfloxacin + Synbiotic

Norfloxacin 400 mg once daily with synbiotic capsules (Streptococcus faecalis JPC 30 million, Clostridium butyricum 2 million, Bacillus mesentericus JPC 1 million, Lactobacillus sporogenes 50 million spores) 2 t.i.d.

DRUG

Norfloxacin + Placebo

Norfloxacin 400 mg once daily with placebo

Trial Locations (1)

110002

Department of Gastroenterology, G B Pant Hospital, New Delhi

All Listed Sponsors
collaborator

Jhaver Research Foundation Limited

UNKNOWN

lead

Govind Ballabh Pant Hospital

OTHER_GOV

NCT00947336 - Evaluation of Safety & Efficacy of Synbiotic on the Incidence and Recurrence of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics | Biotech Hunter | Biotech Hunter